Literature DB >> 21875223

Effects of acute nicotine administration on resting EEG in nonsmokers.

Derek J Fisher1, Richelle Daniels, Natalia Jaworska, Amy Knobelsdorf, Verner J Knott.   

Abstract

Smoking/nicotine has been shown to increase brain arousal states, yet previous studies have failed to distinguish between absolute improvements due to nicotine versus relief from withdrawal symptoms in smokers. This study examined the electrocortical response to nicotine in a nonsmoking population, in order to negate potential withdrawal symptoms. Twenty right-handed, nonsmoking participants were administered nicotine (6 mg) or placebo gum within a double-blind, repeated-measures design. In each session, EEG was recorded during a 2-min, resting, eyes-open condition. Nicotine administration (vs. placebo) resulted in significantly greater frontal (specifically left-frontal) alpha2 power. Similar to previous findings in smokers. The absence of slow-wave changes following nicotine in nonsmokers suggest that these previous results in smokers may be related to withdrawal state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875223     DOI: 10.1037/a0025221

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  10 in total

1.  Acute effects of methadone on EEG power spectrum and event-related potentials among heroin dependents.

Authors:  Farid Motlagh; Fatimah Ibrahim; Rusdi Rashid; Niusha Shafiabady; Tahereh Seghatoleslam; Hussain Habil
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

2.  Effects of acute nicotine on auditory change-related cortical responses.

Authors:  Naofumi Otsuru; Aki Tsuruhara; Eishi Motomura; Hisashi Tanii; Makoto Nishihara; Koji Inui; Ryusuke Kakigi
Journal:  Psychopharmacology (Berl)       Date:  2012-06-17       Impact factor: 4.530

3.  Resting-state EEG, impulsiveness, and personality in daily and nondaily smokers.

Authors:  Olga Rass; Woo-Young Ahn; Brian F O'Donnell
Journal:  Clin Neurophysiol       Date:  2015-05-14       Impact factor: 3.708

4.  COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokers.

Authors:  H Bowers; D Smith; S de la Salle; J Choueiry; D Impey; T Philippe; H Dort; A Millar; M Daigle; P R Albert; A Beaudoin; V Knott
Journal:  Genes Brain Behav       Date:  2015-07-15       Impact factor: 3.449

5.  Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.

Authors:  David E Evans; Steven K Sutton; Jason A Oliver; David J Drobes
Journal:  Psychopharmacology (Berl)       Date:  2014-12-10       Impact factor: 4.530

Review 6.  Overview of potential procedural and participant-related confounds for neuroimaging of the resting state.

Authors:  Niall W Duncan; Georg Northoff
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

7.  Nicotine-induced cortical activation among nonsmokers with moderation by trait cognitive control.

Authors:  Steven K Sutton; Kate Janse Van Rensburg; Kade G Jentink; David J Drobes; David E Evans
Journal:  Psychopharmacology (Berl)       Date:  2016-04-05       Impact factor: 4.530

8.  Tobacco Smoking and the Resting Maternal Brain: A Preliminary Study of Frontal EEG.

Authors:  Haley E Wilbanks; Mariana Von Mohr; Marc N Potenza; Linda C Mayes; Helena J V Rutherford
Journal:  Yale J Biol Med       Date:  2016-06-27

Review 9.  On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations.

Authors:  Diego Lozano-Soldevilla
Journal:  Front Comput Neurosci       Date:  2018-04-04       Impact factor: 2.380

10.  Effect of caffeine on resting-state alpha activity across the human menstrual cycle.

Authors:  Jasmine R Aziz; Alexandra Oprea; Jenna N Bissonnette; Krista M Hull; Kaitlyn Napier; Bronwen Schryver; Elizabeth M Myles; Randy L Newman; Tara S Perrot; Derek J Fisher
Journal:  Psychopharmacology (Berl)       Date:  2022-07-29       Impact factor: 4.415

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.